6NCA
HLA-A2 (A*02:01) bound to a peptide from the Epstein-Barr virus BRLF1 protein
Summary for 6NCA
Entry DOI | 10.2210/pdb6nca/pdb |
Descriptor | Replication and transcription activator, HLA class I histocompatibility antigen, A-2 alpha chain, Beta-2-microglobulin (3 entities in total) |
Functional Keywords | ebv viral peptide, brlf1, hla-a2, immune system |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 60 |
Total formula weight | 896096.96 |
Authors | Stern, L.J.,Selin, L.K.,Song, I.Y. (deposition date: 2018-12-11, release date: 2019-10-23, Last modification date: 2020-01-29) |
Primary citation | Kamga, L.,Gil, A.,Song, I.,Brody, R.,Ghersi, D.,Aslan, N.,Stern, L.J.,Selin, L.K.,Luzuriaga, K. CDR3 alpha drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection. Plos Pathog., 15:e1008122-e1008122, 2019 Cited by PubMed: 31765434DOI: 10.1371/journal.ppat.1008122 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.30000082539 Å) |
Structure validation
Download full validation report